NZ King Salmon at 20 Cents: A First-Half Loss, Then a Doubled Profit Forecast
New Zealand King Salmon has given investors a confusing year, and confusing years are often where the most interesting questions sit. The NZK.NZ stock reported a heavy loss for the first half, and then, a short time later, sharply upgraded its full-year earnings guidance. Both things are true at once, and understanding why is the key to this stock.
New Zealand King Salmon farms, processes, and sells king salmon, mainly from the Marlborough Sounds, into New Zealand and a range of export markets including North America, Australia, Japan, Europe, and China. Salmon farming is a biological business: its results depend heavily on water temperatures, fish survival rates, growth, and feed conditions, all of which can swing from season to season.
Recent Performance
NZK has been a difficult stock to hold. The shares trade around $0.20, down roughly 15% over the past year. Analyst price targets sit a little higher, near $0.31, reflecting a view that the company is worth more if its recovery holds. This is a small-cap stock, and a volatile one.
The share price weakness is understandable given the first-half loss. The more forward-looking signal is the guidance upgrade that followed.
Key Metrics
The figures that frame the case:
- •Share price: around $0.20 NZD
- •First-half revenue: $94.5 million, down 7.1%
- •First-half net loss: $20.8 million
- •Dividend: none currently paid
These are not comfortable numbers. A net loss of $20.8 million for the half, against a small profit in the prior comparable period, is a serious swing. There is no dividend, so this is not an income stock. It is a turnaround and recovery situation, and it should be judged as one. For how we approach loss-making companies and turnaround stories, see our [methodology](/methodology).
The Big Picture
So why the optimism? The answer is in the farming season. Salmon farming results are driven by what happens in the water, and the company reported that summer farming conditions went considerably better than expected. Fish mortality over summer was lower than forecast, feed-out rates stayed strong, and the result was more fish to sell at better size and quality.
That improvement led NZ King Salmon to upgrade its full-year 2026 guidance significantly. Pro-forma underlying earnings (EBITDA) are now forecast at $19 million to $27 million, up from previous guidance of $9 million to $15 million. Pro-forma EBIT guidance moved from a range straddling a small loss to a projected $10 million to $18 million profit. "Pro-forma" simply means the figures are presented on an adjusted, comparable basis. The company also lifted its expected processed harvest volume to 5,800 to 6,100 tonnes.
One number went the other way. The full-year revenue forecast was actually reduced, to around $166.4 million from a prior $195.2 million. The combination, lower revenue but much higher profit guidance, tells you the improvement is about farming efficiency and fish quality rather than selling more dollars of salmon. The first-half loss largely reflected the period before the strong summer; the upgrade reflects the season that followed.
Salmon farming sits alongside New Zealand's wider seafood industry. Investors interested in the sector may want to compare NZK with the larger and more diversified [Sanford](/stocks/sanford), which spans wild-catch and aquaculture.
What to Watch
Three things will shape the outlook.
First, farming conditions. This is the single biggest driver. Water temperatures, fish survival, and growth rates will make or break future results. Warmer summers are a known long-term risk for salmon in New Zealand waters.
First-half losses can be misleading in a seasonal business, so second, watch the full-year result to see whether the upgraded guidance is actually delivered.
Third, the path to consistent profit. One good season is encouraging. The real test is whether NZ King Salmon can string together steady profitability and eventually return to paying a dividend.
The Bottom Line
The bull case for NZ King Salmon is a sharp guidance upgrade driven by genuinely better farming conditions, a low share price, and analyst targets above the current level. The bear case is a first-half loss, no dividend, falling revenue guidance, and a biological business exposed to warming waters and volatile fish performance. At around $0.20, this is a speculative recovery play, suitable only for investors comfortable with real risk and a bumpy ride.
*This article is for informational purposes only and does not constitute financial advice. Always do your own research or consult a licensed financial adviser before making investment decisions. Figures are drawn from publicly available company disclosures and market data and may change after publication. See our [methodology](/methodology) for how we approach these articles.*